Ki Summary

Reaction Details

Report a problem with these data

Target

Neuropeptide Y receptor type 5

Ligand

BDBM50304306

Substrate/Competitor

n/a

Meas. Tech.

ChEMBL_606453 (CHEMBL1074018)

IC50

5.4±n/a nM

Citation

Haga, Y; Sakamoto, T; Shibata, T; Nonoshita, K; Ishikawa, M; Suga, T; Takahashi, H; Takahashi, T; Takahashi, H; Ando, M; Murai, T; Gomori, A; Oda, Z; Kitazawa, H; Mitobe, Y; Kanesaka, M; Ohe, T; Iwaasa, H; Ishii, Y; Ishihara, A; Kanatani, A; Fukami, T Discovery of trans-N-[1-(2-fluorophenyl)-3-pyrazolyl]-3-oxospiro[6-azaisobenzofuran-1(3H),1'-cyclohexane]-4'-carboxamide, a potent and orally active neuropeptide Y Y5 receptor antagonist. Bioorg Med Chem17:6971-82 (2009) [PubMed] Article

More Info.:

Get all data from this article, Assay Method

Neuropeptide Y receptor type 5

Name:

Neuropeptide Y receptor type 5

Synonyms:

Type:

Enzyme

Mol. Mass.:

50746.64

Organism:

Homo sapiens (Human)

Description:

Q15761

Residue:

445

Sequence:

MDLELDEYYNKTLATENNTAATRNSDFPVWDDYKSSVDDLQYFLIGLYTFVSLLGFMGNL
LILMALMKKRNQKTTVNFLIGNLAFSDILVVLFCSPFTLTSVLLDQWMFGKVMCHIMPFL
QCVSVLVSTLILISIAIVRYHMIKHPISNNLTANHGYFLIATVWTLGFAICSPLPVFHSL
VELQETFGSALLSSRYLCVESWPSDSYRIAFTISLLLVQYILPLVCLTVSHTSVCRSISC
GLSNKENRLEENEMINLTLHPSKKSGPQVKLSGSHKWSYSFIKKHRRRYSKKTACVLPAP
ERPSQENHSRILPENFGSVRSQLSSSSKFIPGVPTCFEIKPEENSDVHELRVKRSVTRIK
KRSRSVFYRLTILILVFAVSWMPLHLFHVVTDFNDNLISNRHFKLVYCICHLLGMMSCCL
NPILYGFLNNGIKADLVSLIHCLHM

BDBM50304306

n/a

Name

BDBM50304306

Synonyms:

CHEMBL607088 | trans-3-Oxo-N-(3-phenyl-1H-pyrazol-5-yl)-3H-spiro[4-aza-2-benzofuran-1,1'-cyclohexane]-4'-carboxamide

Type

Small organic molecule

Emp. Form.

C22H20N4O3

Mol. Mass.

388.4192

SMILES

O=C(Nc1cc(n[nH]1)-c1ccccc1)[C@H]1CC[C@@]2(CC1)OC(=O)c1ncccc21 |r,wU:17.22,wD:14.15,(10.49,-8.76,;11.26,-10.1,;12.8,-10.1,;13.67,-11.37,;13.16,-12.83,;14.39,-13.76,;15.65,-12.89,;15.21,-11.41,;14.35,-15.3,;13,-16.03,;12.96,-17.57,;14.28,-18.38,;15.64,-17.63,;15.67,-16.09,;10.48,-11.43,;8.94,-11.43,;8.17,-12.77,;8.94,-14.09,;10.48,-14.09,;11.25,-12.77,;9.86,-15.35,;8.95,-16.61,;9.43,-18.07,;7.48,-16.13,;6.14,-16.9,;4.81,-16.13,;4.81,-14.58,;6.14,-13.81,;7.48,-14.58,)|

Structure